Patents by Inventor Anne Strouse

Anne Strouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKERS SPECIFIC FOR PLURIPOTENT STEM CELLS, AND METHODS OF USING THE SAME
    Publication number: 20230122115
    Abstract: The present disclosure provides markers specific for pluripotent stem cells. In particular, the present disclosure relates to nucleic acid and polypeptide markers that are selectively expressed by pluripotent stem cells; and to methods for detecting the presence and/or absence of one or a plurality of pluripotent stem cells, by detecting such markers.
    Type: Application
    Filed: September 9, 2022
    Publication date: April 20, 2023
    Applicant: FUJIFILM Corporation
    Inventors: Tom BURKE, Steven SMITH, Anne STROUSE
  • METHODS FOR THE PRODUCTION OF MULTIPLE LINEAGES FROM INDUCED PLURIPOTENT STEM CELLS USING CHARGED SURFACES
    Publication number: 20220251516
    Abstract: The present disclosure provides methods of producing progenitor cells from induced pluripotent stem cells, wherein the progenitor cells comprise endothelial cells, pericytes, brain microvascular endothelial cells (BMECs), mesenchymal stem cells (MSCs), hematopoietic precursor cells (HPCs), microglia or neural precursor cells (NPCs).
    Type: Application
    Filed: June 15, 2020
    Publication date: August 11, 2022
    Applicants: FUJIFILM Cellular Dynamics, Inc., FUJIFILM Holdings America Corporation
    Inventors: Deepika RAJESH, Christie MUNN, Sarah BURTON, Madelyn GOEDLAND, Michael McLACHLAN, Abbey MUSINSKY, Kwi Hye KIM, Michael HANCOCK, Makiko OHSHIMA, Anne STROUSE, Sarah DICKERSON
  • Generating mature lineages from induced pluripotent stem cells with MECP2 disruption
    Patent number: 10961505
    Abstract: Provided herein are methods for the efficient in vitro maintenance, expansion, culture, and/or differentiation of pluripotent cells with disruption of the MeCP2 gene into various erythroid, myeloid, lymphoid, or endoderm lineages, particularly mature erythrocytes. The pluripotent cells may be maintained and differentiated under defined conditions; thus, the use of mouse feeder cells or serum is not required in certain embodiments for the differentiation of the precursor cells.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: March 30, 2021
    Assignee: FUJIFILM Cellular Dynamics, Inc.
    Inventors: Deepika Rajesh, Anne Strouse, Sarah Burton, Christie Munn, Bradley Swanson
  • GENERATING MATURE LINEAGES FROM INDUCED PLURIPOTENT STEM CELLS WITH MECP2 DISRUPTION
    Publication number: 20180179496
    Abstract: Provided herein are methods for the efficient in vitro maintenance, expansion, culture, and/or differentiation of pluripotent cells with disruption of the MeCP2 gene into various erythroid, myeloid, lymphoid, or endoderm lineages, particularly mature erythrocytes. The pluripotent cells may be maintained and differentiated under defined conditions; thus, the use of mouse feeder cells or serum is not required in certain embodiments for the differentiation of the precursor cells.
    Type: Application
    Filed: October 5, 2017
    Publication date: June 28, 2018
    Inventors: Deepika RAJESH, Anne STROUSE, Sarah BURTON, Christie MUNN, Bradley SWANSON
  • METHODS FOR CELL REPROGRAMMING AND GENOME ENGINEERING
    Publication number: 20160281063
    Abstract: Methods for producing engineered induced pluripotent stem (iPS) cells are provided comprising introducing a first nucleic acid into somatic cells for integration into their genome and reprogramming the cells to produce engineered iPS cells having the nucleic acid integrated into their genome. For example, in certain aspects the cells are reprogrammed by introduction of a genetic element that expresses one or more reprogramming factor and culturing of the cells under conditions sufficient to produce reprogrammed cells.
    Type: Application
    Filed: February 23, 2016
    Publication date: September 29, 2016
    Applicant: Cellular Dynamics International, Inc.
    Inventors: Thomas J. BURKE, Michael MILLER, Michael McLACHLAN, Sarah Jane DICKERSON, Anne STROUSE
  • METHODS FOR CELL REPROGRAMMING AND GENOME ENGINEERING
    Publication number: 20130040302
    Abstract: Methods for producing engineered induced pluripotent stem (iPS) cells are provided comprising introducing a first nucleic acid into somatic cells for integration into their genome and reprogramming the cells to produce engineered iPS cells having the nucleic acid integrated into their genome. For example, in certain aspects the cells are reprogrammed by introduction of a genetic element that expresses one or more reprogramming factor and culturing of the cells under conditions sufficient to produce reprogrammed cells.
    Type: Application
    Filed: July 11, 2012
    Publication date: February 14, 2013
    Inventors: Thomas J. Burke, Michael Miller, Michael McLachlan, Sarah Jane Dickerson, Anne Strouse